New Research Supports Custom Allergy Drop Treatment
We’re always looking for new research about sublingual immunotherapy and related topics. In fact, twice a year we find the most up-to-date published articles and put those applicable into our bibliography. It now houses nearly 1,300 articles that have been reviewed by our Medical Advisor and author of the La Crosse Method™ Protocol, Dr. Mary…Read More
Sublingual Immunotherapy for Peanut Allergy Research Update
While awareness, acceptance, and use of sublingual immunotherapy — or allergy drops — has become mainstream in the past several decades in parts of Europe, in the U.S. it has been slower. When looking at disease modifying treatments, safety and effectiveness are at top of mind for patients and providers. Research is the most accepted…Read More
Does SLIT impact asthma? New review indicates yes.
Big news for sublingual immunotherapy came in the form of a comparative effectiveness review recently. A group of allergy researchers compared 31 subcutaneous immunotherapy studies, 18 sublingual immunotherapy studies, and 5 combined studies “to assess the efficacy and safety of immunotherapy for treating allergic asthma.” The results showed that overall, immunotherapy is a valid treatment…Read More
SLIT for Peanut Allergy: What we’re learning from clinical experience
When my father, Dr. David Morris, began offering sublingual immunotherapy (SLIT) more than four decades ago, his motivation was to offer patients who were not having success with allergy injection immunotherapy another disease-modifying option. Initially, the patients who gravitated to SLIT were mold-allergic patients who were not helped by or unable to tolerate injection immunotherapy.…Read More